Iguana Healthcare Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Iguana Healthcare Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-100,000	Closed	-$595K	–	78
2017 Q4	$595K	Sell	100,000 -175,000	-64%	-$1.2M	0.39%	57
2017 Q3	$2.04M	Buy	275,000 +25,000	+10%	+$208K	1.11%	34
2017 Q2	$2.34M	Hold	250,000	–	–	1.32%	32
2017 Q1	$1.82M	Sell	250,000 -20,000	-7%	-$144K	0.9%	38
2016 Q4	$2M	Sell	270,000 -30,000	-10%	-$216K	1.19%	30
2016 Q3	$1.81M	Buy	300,000 +150,000	+100%	+$709K	0.32%	69
2016 Q2	$674K	Buy	+150,000	New	+$563K	0.27%	72

Other funds holding CCXI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Iguana Healthcare Management's CCXI Position: Q1 2018 in Review

Iguana Healthcare Management sold out of ChemoCentryx, Inc. (CCXI) in Q1 2018, closing a stake of 100,000 shares — an estimated $595K sold.

Iguana Healthcare Management first reported a position in CCXI in Q2 2016 and held it in 7 quarters. The position peaked at $2.34M in Q2 2017. 100 funds tracked by Wall St. Rank hold CCXI as of Q1 2018.

Iguana Healthcare Management reported no remaining ChemoCentryx, Inc. position as of Q1 2018 after selling out during the quarter.
Iguana Healthcare Management sold 100,000 ChemoCentryx, Inc. shares in Q1 2018, an estimated $595K.
Iguana Healthcare Management first reported a position in ChemoCentryx, Inc. in Q2 2016 and held it in 7 quarters.
Iguana Healthcare Management's ChemoCentryx, Inc. position peaked at $2.34M in Q2 2017.
100 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.